Shore Capital has reiterated its sell rating on HSBC shares, warning that the bank's current valuation leaves little room for disappointment despite a confident outlook from management. The broker highlights that HSBC benefits from an unusually favorable interest rate environment and prioritizes dividends over buybacks, suggesting limited growth opportunities. While HSBC shows strong near-term performance and earnings growth, Shore Capital remains cautious about the sustainability of profitability through economic cycles. HSBC's third-quarter results are expected on October 27.
Telsey Advisory lowered G-III Apparel Group's price target from $38 to $32, reflecting mixed financial results and challenges integrating the Marc Jacobs brand. The company's net sales dropped from $613.3 million to $554.1 million, but GAAP net incom...
The Toro Company reported strong third-quarter results, surpassing analyst expectations with earnings of $1.33 per share and revenues of $1.23 billion. This marks a year-over-year increase in earnings, reflecting improved profitability driven by stro...
Lands' End reported Q2 fiscal results with revenue rising 2.7% to $302 million, beating analyst expectations, while adjusted EPS missed slightly at $0.09 versus $0.10 forecast. The company improved profitability from a year ago, turning an adjusted l...
Planet Labs is set to report its Q2 earnings, with analysts expecting a loss of $0.02 per share, a 33.3% improvement from last year. Revenue is estimated at $104.12 million. Despite a significant stock decline, trading 27% below its 200-day average, ...
CVS Health reported a 7.3% revenue increase in Q2 to $106.1 billion and raised its full-year revenue forecast to at least $414 billion, alongside improved earnings per share guidance. Despite UBS lowering its price target to $118, analysts like Jeffe...
